Cannabis Extract in Refractory Epilepsy Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this study is to examine whether a low dose of CBD+THC will decrease the frequency of convulsive seizures in adults with drug-resistant epilepsy, when used in addition to standard anti-epileptic drugs (AEDs). This study will also study the genes associated with epilepsy and whether different epileptic syndromes respond to treatment with CBD+THC.
Epistemonikos ID: 8d7ffa3efb4e6ab3f02fdec43e6e86b20405ac29
First added on: Apr 23, 2019